As IHIF EMEA 2026 convenes under the theme Returns Redefined, Value Reimagined, a new briefing published by Valpas exposes a structural gap in how hotel assets are valued: every physical condition risk in a hotel — structural integrity, fire safety, water quality, HVAC performance — has a standardised inspection, a certification requirement, and a recognised impact on transaction value. Every risk except one.
Bed bug infestation risk has historically sat in facilities budgets as an unpredictable operational cost: invisible in due diligence, unquantifiable in underwriting, absent from ESG reporting. The briefing — titled The Valuation Blind Spot — maps the regulatory, technological, and market forces that are converging to close this gap, and examines what the evidence from Paris and other early-adopting markets reveals about how quickly the shift is occurring.

Infestations have become structural, not temporary
Industry data paints a picture that should concern anyone conducting due diligence on a hotel asset. Hotels average 7.1 bed bug infestations every five years. Seventy percent of chemically treated infestations require multiple treatment rounds to resolve. Fifty percent require retreatment within 12 months. At the same time, EU regulatory action is tightening restrictions on neonicotinoid-based pesticides — the chemicals that underpin most reactive treatment. The European Commission’s forthcoming EU Ecolabel revision will formally distinguish between reactive biocide treatments and verified prevention-based systems.

The reactive model is not just ineffective — it is becoming non-viable. For a 200-room urban luxury hotel experiencing two incidents per year, the annualised P&L exposure sits between €27,000 and €160,000 in direct costs — room displacement, treatment, settlement of legal claims, compensation, operational disruption — before reputational damage. As treatment options narrow, this figure escalates rather than stabilises.

“Every hotel investor evaluates fire safety compliance, structural condition, and environmental performance before a transaction. Pest condition is the only physical risk where there is no data, no verification standard, and no pricing in the model. That’s a blind spot — and the market is beginning to correct it.” — Martim Gois, CEO and Co-founder, Valpas

How the economics shift: from P&L volatility to balance sheet infrastructure
The briefing details how permanent safety infrastructure changes where pest-related costs appear in the financial structure of a hotel asset. Under the reactive model, every infestation triggers unpredictable operational expenditure that flows directly through the P&L — depressing NOI unpredictably and compounding across a portfolio. Permanent infrastructure replaces this with a fixed annual commitment per room that qualifies for capitalisation as an asset improvement: costs move from OPEX to the balance sheet, NOI stabilises, and the asset carries documented permanent safety that supports favourable insurance terms.

For operators, the shift is direct: unpredictable costs that erode gross operating profit — emergency treatments, room blocks, guest compensation, and the reputational drag that quietly compresses ADR — are replaced by fixed safety infrastructure. For owners, the improvement flows through to NOI and supports the asset’s pricing in a transaction or refinancing.

Reputation damage has become permanent and algorithmic
The briefing documents how a single unmanaged incident now generates a review signal that persists indefinitely across every platform surfacing guest feedback. AI booking agents and travel assistants — trained on structured, verifiable data — are already making recommendations on behalf of corporate and leisure travellers. A hotel without verified permanent safety is a hotel these systems cannot confidently recommend. Simultaneously, corporate travel managers are formalising safety and duty-of-care requirements: GBTA data shows safety concerns among corporate travel professionals reached 46%, rising nine percentage points year-on-year. Verifiable permanent safety is entering RFP criteria.

The ESG gap is becoming auditable
Hotels are among the heaviest indoor users of neonicotinoid-based pesticides — the same class of chemicals linked to the collapse of pollinator populations globally, 7,000 times more toxic to bees than DDT. As CSRD mandates expand in 2026 to require audited ESG disclosures, the gap between published sustainability commitments and actual chemical pesticide use is becoming auditable. Permanent safety infrastructure closes it: zero pesticides, real-time verification, 1.4 tonnes of CO₂e reduction per room per year compared to reactive chemical cycles, and full alignment with GRESB, BREEAM, LEED, EU Ecolabel, GSTC, Travalyst, and WSHA frameworks.

Paris moved in under eighteen months
The briefing presents Paris as the clearest evidence of adoption velocity. Following the 2023 bed bug crisis, the luxury market moved through three adoption tiers — from global branded scale (Marriott Rive Gauche, 757 rooms, owned by Aroundtown) through branded boutique luxury (Prince de Galles, 159 rooms) to ultra-boutique independents — in under eighteen months. The pattern is consistent: once a visible brand in a market certifies, the question for peer properties shifts from whether to when.

What investment professionals are beginning to ask
The briefing concludes with a due diligence framework that leading investment professionals are starting to apply in current hotel transactions:

1. Request real-time pest condition certification or verified permanent safety documentation.
2. Ask for the pest control intervention log for the past 24 months.
3. If no verified proof exists, factor a discount for structural recurring cost risk, capex to install permanent infrastructure, and reputational exposure.
4. Benchmark against comparable certified assets in the market to quantify the valuation differential.

“The question is not whether this standard arrives. It is whether the assets in a given portfolio lead it or adapt to it later — and what the valuation differential looks like by the time they do.” — Martim Gois, CEO and Co-founder, Valpas